Nanomedicine · 2017 · 27 citations · 43 references
PharmacyOncologyPharmaceuticsCancer PharmacologyChemotherapyDrug DeliveryCancer Drug DeliveryDrug Delivery EngineeringDrug EncapsulationEmulsion FormulationNanocarriers For TherapeuticsNanoparticle DesignChemotherapy DeliveryControlled Release In EmulsionsControlled-release EmulsionsCytotoxicity AssaysDrug-loaded EmulsionsEmulsionsEncapsulation EfficiencyPh-responsive Delivery
AIM: Developing pH-responsive multiple emulsion platforms for effective glioblastoma multiforme therapy with reduced toxicity, a drug release study and modeling. MATERIALS & METHODS: Cancer cell line: U87 MG, multiple emulsions with pH-responsive biopolymer and encapsulated doxorubicin (DOX); preparation of multiple emulsions in a Couette-Taylor flow biocontactor, in vitro release study of DOX (fluorescence intensity analysis), in vitro cytotoxicity study (alamarBlue cell viability assay) and numerical simulation of DOX release rates. RESULTS: The multiple emulsions offered a high DOX encapsulation efficiency (97.4 ± 1%) and pH modulated release rates of a drug. Multiple emulsions with a low concentration of DOX (0.02 μM) exhibited broadly advanced cell (U87 MG) cytotoxicity than free DOX solution used at the same concentration. CONCLUSION: Emulsion platforms could be explored for potential delivery of chemotherapeutics in glioblastoma multiforme therapy.
43
Caroline F. Thorn, Connie Oshiro, Sharon Marsh et al. · Pharmacogenetics and Genomics · 2010 · 1.6K citations · Full text
Magnetic nanoparticle drug delivery systems for targeting tumor
Vicky Mody, Arthur G. Cox, Samit Shah et al. · Applied Nanoscience · 2013 · 492 citations · Full text
Pharmacy, Oncology, Pharmaceutics +17
Endothelial Nitric Oxide Synthase-Dependent Superoxide Generation from Adriamycin
Jeannette Vásquez‐Vivar, Pavel Martásek, Neil Hogg et al. · Biochemistry · 1997 · 371 citations